Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Hepatitis B virus | 2 | 2017 | 882 | 0.77 | Why? |
| Hepatitis A virus | 1 | 2017 | 68 | 0.64 | Why? |
| Hepatitis B Antibodies | 1 | 2016 | 142 | 0.61 | Why? |
| Herpesvirus 3, Human | 1 | 2017 | 228 | 0.56 | Why? |
| Hepatitis B Vaccines | 1 | 2016 | 245 | 0.55 | Why? |
| Ireland | 8 | 2021 | 1456 | 0.52 | Why? |
| Hepatitis B, Chronic | 1 | 2016 | 616 | 0.39 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.35 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.34 | Why? |
| von Willebrand Factor | 3 | 2021 | 668 | 0.32 | Why? |
| Azithromycin | 1 | 2020 | 3943 | 0.29 | Why? |
| HIV Infections | 6 | 2020 | 11620 | 0.24 | Why? |
| Fatigue | 3 | 2021 | 2479 | 0.22 | Why? |
| Acute-Phase Reaction | 1 | 2021 | 116 | 0.21 | Why? |
| Interferon-alpha | 2 | 2018 | 1442 | 0.19 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.19 | Why? |
| Anti-Bacterial Agents | 2 | 2021 | 10083 | 0.19 | Why? |
| Hepatitis Viruses | 1 | 2017 | 38 | 0.17 | Why? |
| STAT Transcription Factors | 1 | 2018 | 173 | 0.17 | Why? |
| Protein Precursors | 1 | 2020 | 425 | 0.16 | Why? |
| Ubiquitins | 1 | 2018 | 202 | 0.16 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.16 | Why? |
| Blood Coagulation Disorders | 2 | 2020 | 2040 | 0.16 | Why? |
| Off-Label Use | 1 | 2020 | 553 | 0.15 | Why? |
| Virus Latency | 1 | 2017 | 251 | 0.15 | Why? |
| Drugs, Generic | 1 | 2017 | 136 | 0.15 | Why? |
| Social Identification | 1 | 2016 | 120 | 0.14 | Why? |
| Janus Kinases | 1 | 2018 | 414 | 0.14 | Why? |
| Proteolysis | 1 | 2018 | 751 | 0.13 | Why? |
| Drug Substitution | 1 | 2017 | 385 | 0.13 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.13 | Why? |
| Education, Medical, Graduate | 2 | 2017 | 2082 | 0.12 | Why? |
| Substance Abuse, Intravenous | 1 | 2017 | 411 | 0.12 | Why? |
| Antimicrobial Stewardship | 1 | 2021 | 931 | 0.12 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.11 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.11 | Why? |
| Education, Medical, Continuing | 1 | 2017 | 638 | 0.10 | Why? |
| HIV | 1 | 2017 | 1116 | 0.10 | Why? |
| Attitude of Health Personnel | 3 | 2017 | 4741 | 0.10 | Why? |
| Endothelial Cells | 1 | 2020 | 2048 | 0.10 | Why? |
| Frailty | 1 | 2021 | 1432 | 0.10 | Why? |
| Patients | 1 | 2017 | 1167 | 0.09 | Why? |
| Learning | 1 | 2017 | 1181 | 0.09 | Why? |
| Anti-Retroviral Agents | 1 | 2017 | 1099 | 0.09 | Why? |
| Disabled Persons | 1 | 2019 | 1152 | 0.09 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.09 | Why? |
| Hepacivirus | 1 | 2017 | 1509 | 0.09 | Why? |
| Medication Adherence | 1 | 2017 | 1270 | 0.08 | Why? |
| Male | 17 | 2021 | 367725 | 0.08 | Why? |
| Homeless Persons | 1 | 2017 | 1171 | 0.08 | Why? |
| Physician-Patient Relations | 1 | 2016 | 1266 | 0.08 | Why? |
| Humans | 31 | 2021 | 930598 | 0.08 | Why? |
| Adult | 13 | 2021 | 244371 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Hepatitis C | 1 | 2017 | 1514 | 0.07 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.07 | Why? |
| Female | 16 | 2021 | 380317 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 5993 | 0.07 | Why? |
| Aging | 1 | 2021 | 3581 | 0.07 | Why? |
| Aged | 11 | 2021 | 215776 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.07 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.06 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Consensus | 1 | 2017 | 6345 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Thrombospondin 1 | 1 | 2021 | 29 | 0.06 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.06 | Why? |
| HIV Long-Term Survivors | 1 | 2020 | 56 | 0.05 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.05 | Why? |
| Physicians | 2 | 2017 | 4214 | 0.05 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.05 | Why? |
| Patient Admission | 1 | 2017 | 5250 | 0.05 | Why? |
| Physical Exertion | 1 | 2021 | 176 | 0.05 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2020 | 234 | 0.05 | Why? |
| Autonomic Nervous System | 1 | 2021 | 148 | 0.05 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.05 | Why? |
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2018 | 16 | 0.05 | Why? |
| HIV Core Protein p24 | 1 | 2018 | 48 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Walk Test | 1 | 2021 | 461 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2020 | 22116 | 0.04 | Why? |
| Clone Cells | 1 | 2018 | 312 | 0.04 | Why? |
| ADAMTS13 Protein | 1 | 2021 | 363 | 0.04 | Why? |
| Cross-Cultural Comparison | 1 | 2019 | 338 | 0.04 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2018 | 249 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Ubiquitination | 1 | 2018 | 343 | 0.04 | Why? |
| Interinstitutional Relations | 1 | 2018 | 170 | 0.04 | Why? |
| Immunophenotyping | 1 | 2021 | 1290 | 0.04 | Why? |
| Treatment Outcome | 2 | 2020 | 51732 | 0.04 | Why? |
| HEK293 Cells | 2 | 2021 | 8394 | 0.04 | Why? |
| Amino Acid Motifs | 1 | 2018 | 620 | 0.04 | Why? |
| Ubiquitin-Protein Ligases | 1 | 2018 | 249 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Qualitative Research | 2 | 2019 | 4337 | 0.04 | Why? |
| Community-Based Participatory Research | 1 | 2018 | 271 | 0.04 | Why? |
| Canada | 2 | 2019 | 6018 | 0.04 | Why? |
| Lung | 2 | 2021 | 31049 | 0.04 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Antiviral Agents | 2 | 2018 | 41703 | 0.03 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.03 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| Drug Costs | 1 | 2017 | 313 | 0.03 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Heart Rate | 1 | 2021 | 1527 | 0.03 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2020 | 994 | 0.03 | Why? |
| Faculty, Medical | 1 | 2017 | 595 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2021 | 2742 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Drug Resistance, Bacterial | 1 | 2021 | 1414 | 0.03 | Why? |
| Clinical Clerkship | 1 | 2016 | 403 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2020 | 1731 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Interprofessional Relations | 1 | 2017 | 1013 | 0.03 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.02 | Why? |
| Blood Pressure | 1 | 2021 | 2198 | 0.02 | Why? |
| Uncertainty | 1 | 2020 | 1888 | 0.02 | Why? |
| Hospitals, Teaching | 1 | 2017 | 1609 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.02 | Why? |
| Personnel Staffing and Scheduling | 1 | 2017 | 1578 | 0.02 | Why? |
| Leukocytes, Mononuclear | 1 | 2018 | 2115 | 0.02 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Health Status | 1 | 2021 | 3259 | 0.02 | Why? |
| Medical Staff, Hospital | 1 | 2017 | 1258 | 0.02 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.02 | Why? |
| Workload | 1 | 2017 | 1887 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.02 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Perception | 1 | 2017 | 2827 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Gene Expression Regulation | 1 | 2018 | 4020 | 0.02 | Why? |
| Hospitals, University | 1 | 2017 | 4173 | 0.02 | Why? |
| Radiography, Thoracic | 1 | 2021 | 5486 | 0.02 | Why? |
| Ambulatory Care | 1 | 2021 | 4947 | 0.02 | Why? |
| Education, Medical, Undergraduate | 1 | 2016 | 1392 | 0.02 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.02 | Why? |
| Health Services Needs and Demand | 1 | 2017 | 3419 | 0.02 | Why? |
| Interleukin-6 | 1 | 2020 | 7522 | 0.01 | Why? |
| Protein Binding | 1 | 2018 | 11430 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.01 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.01 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2020 | 6166 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.01 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.01 | Why? |
| Students, Medical | 1 | 2016 | 4032 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.01 | Why? |
| Internship and Residency | 1 | 2017 | 4987 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Anxiety | 1 | 2021 | 17311 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.01 | Why? |
| Time Factors | 1 | 2017 | 31397 | 0.01 | Why? |
Bergin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(183)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(157)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_